首页 › 基金 › Long Focus Capital Management, LLC › BNTX

Long Focus Capital Management, LLC 对 BNTX 的持仓历史

BIONTECH SE · 医疗保健

Long Focus Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 BNTX(BIONTECH SE)632,000 股,市值约 US$62.1M,约占其申报组合的 2.82%,在其申报持仓中市值排名第 9 位。 Long Focus Capital Management, LLC 最近 8 个申报季度中有 8 个季度披露了 BNTX 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q3 2026)632.00K 股
申报持仓市值$62.13M
组合权重2.82%
首次申报Q4 2024
最近变动增持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Long Focus Capital Management, LLC 对 BNTX 的持仓演变

Long Focus Capital Management, LLC 于 Q4 2024 首次披露 BNTX 持仓:910,000 股(约 US$103.7M)。 在 8 次申报中,Long Focus Capital Management, LLC 5 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 632,000 股、市值约 US$62.1M,环比增持 8,000 股。。 持仓曾出现大幅变动:Q1 2025 减持约 83% (随后一个季度股价上涨 17%)、Q2 2025 增持约 31% (随后一个季度股价下跌 7%)、Q3 2025 增持约 91% (随后一个季度股价下跌 3%)。

逐季持仓明细

季度股数金额变化
Q4 2024 910.00K $103.69M 新进
Q1 2025 159.00K $14.48M 减持
Q2 2025 207.90K $22.14M 增持
Q3 2025 397.65K $39.22M 增持
Q4 2025 507.65K $48.33M 增持
Q1 2026 624.00K $55.46M 增持
Q2 2026 624.00K $58.06M 持有
Q3 2026 632.00K $62.13M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 BNTX 与 13F 数据

BNTX(BIONTECH SE)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 BNTX,申报仓位最大的包括:Davern Capital Partners, LP (US$67.1M), GSK plc (US$65.7M), Logos Global Management LP (US$63.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BNTX 的基金

查看 BNTX 的全部基金持有人 →

常见问题

How long has Long Focus Capital Management, LLC held BNTX?

Long Focus Capital Management, LLC has disclosed BNTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Long Focus Capital Management, LLC's current position in BNTX?

As of Q3 2026, Long Focus Capital Management, LLC holds 632.00K shares of BNTX (BIONTECH SE), valued at $62.13M, representing 2.82% of its reported portfolio and ranking #9.

Has Long Focus Capital Management, LLC been buying or selling BNTX?

In the latest 13F filing (Q3 2026), Long Focus Capital Management, LLC increased its position in BNTX.

Which other funds hold BNTX?

Other major institutional holders of BNTX include Davern Capital Partners, LP, GSK plc, Logos Global Management LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.